3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Hepatocellular
52
Carcinoma, Renal Cell
25
Liver Neoplasms
23
Neoplasms
19
Carcinoma, Non-Small-Cell Lung
16
Breast Neoplasms
16
Kidney Neoplasms
11
Leukemia, Myeloid, Acute
9
Melanoma
8
Glioblastoma
8
Sarcoma
7
Prostatic Neoplasms
7
Neoplasm Metastasis
7
Brain Neoplasms
7
Thyroid Neoplasms
6
Ovarian Neoplasms
6
Lung Neoplasms
6
Pancreatic Neoplasms
5
Gliosarcoma
5
Urinary Bladder Neoplasms
4
Recurrence
4
Leukemia, Myelomonocytic, Chronic
4
Leukemia
4
Carcinoma
4
Rectal Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Myelodysplastic Syndromes
3
Multiple Myeloma
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Leiomyosarcoma
3
Interventions
Cisplatin
4
Pemetrexed
3
Etoposide
3
Topotecan
2
Gemcitabine
2
Carboplatin
2
vosaroxin
1
vinflunine
1
veliparib
1
taxane
1
pomalidomide
1
pembrolizumab
1
liposomal doxorubicin
1
etoposide phosphate
1
enzalutamide
1
apalutamide
1
abiraterone
1
Vinorelbine
1
Tomography, X-Ray Computed
1
Temozolomide
1
Radiation
1
RRx-001
1
Positron-Emission Tomography
1
Podophyllotoxin
1
Platinum
1
Paclitaxel
1
Irinotecan
1
Histamine Antagonists
1
GSK2879552
1
Epinephrine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinoma, Small Cell
×
Sorafenib
×
Clear all
No trials found.